← back to search

Yujie Zhang

Fudan University · CN
Area of research
Biomaterials · Biomedical Engineering
Research interest
Research interests include Drug delivery, In vivo, Micelle, Tumor microenvironment, Cancer research, and Materials science.
h-index
citations
2,627
works
24
NIH funding
primary concept
email

Recent publications

Penetrable Nanoplatform for “Cold” Tumor Immune Microenvironment Reeducation
Advanced Science 2020cited by 82position: middledoi
Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic
Journal of Controlled Release 2020cited by 42position: middledoi
Aberrant functional connectivity between the suprachiasmatic nucleus and the superior temporal gyrus: Bridging RORA gene polymorphism with diurnal mood variation in major depressive disorder
Journal of Psychiatric Research 2020cited by 21position: middledoi
Microthrombus‐Targeting Micelles for Neurovascular Remodeling and Enhanced Microcirculatory Perfusion in Acute Ischemic Stroke
Advanced Materials 2019cited by 185position: middledoi
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Advanced Science 2019cited by 126position: middledoi
Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer
Nano Letters 2019cited by 68position: middledoi
Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer
Advanced Functional Materials 2019cited by 67position: firstdoi
Dandelion‐Like Tailorable Nanoparticles for Tumor Microenvironment Modulation
Advanced Science 2019cited by 66position: middledoi
Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy
Nano Letters 2018cited by 432position: middledoi
Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia
Advanced Science 2018cited by 164position: middledoi
Sequentially Triggered Nanoparticles with Tumor Penetration and Intelligent Drug Release for Pancreatic Cancer Therapy
Advanced Science 2018cited by 117position: middledoi
Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy
Biomaterials 2018cited by 85position: firstdoi
Reactive Oxygen Species-Biodegradable Gene Carrier for the Targeting Therapy of Breast Cancer
ACS Applied Materials & Interfaces 2018cited by 52position: middledoi
Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy
ACS Applied Materials & Interfaces 2018cited by 45position: middledoi
Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy
Theranostics 2018cited by 44position: middledoi
Biomacromolecules as carriers in drug delivery and tissue engineering
Acta Pharmaceutica Sinica B 2017cited by 412position: firstdoi
Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
Acta Pharmaceutica Sinica B 2017cited by 136position: middledoi
Biomimetic Human Serum Albumin Nanoparticle for Efficiently Targeting Therapy to Metastatic Breast Cancers
ACS Applied Materials & Interfaces 2017cited by 74position: middledoi
ROS-Switchable Polymeric Nanoplatform with Stimuli-Responsive Release for Active Targeted Drug Delivery to Breast Cancer
ACS Applied Materials & Interfaces 2017cited by 60position: middledoi
Substance P Mediated DGLs Complexing with DACHPt for Targeting Therapy of Glioma
ACS Applied Materials & Interfaces 2017cited by 23position: middledoi
T7 Peptide-Functionalized PEG-PLGA Micelles Loaded with Carmustine for Targeting Therapy of Glioma
ACS Applied Materials & Interfaces 2016cited by 104position: middledoi
Dual Functional Peptide-Driven Nanoparticles for Highly Efficient Glioma-Targeting and Drug Codelivery
Molecular Pharmaceutics 2016cited by 48position: middledoi
Cell Microenvironment-Controlled Antitumor Drug Releasing-Nanomicelles for GLUT1-Targeting Hepatocellular Carcinoma Therapy
ACS Applied Materials & Interfaces 2015cited by 65position: middledoi
Choline Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy
ACS Applied Materials & Interfaces 2015cited by 64position: middledoi
UPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain glioma
Biomaterials 2014cited by 66position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Tao Sun · Fudan University20 papers (2016–2020)Yifei Lü · Fudan University18 papers (2015–2019)Qinjun Chen · Fudan University17 papers (2016–2020)Xi He · Fudan University13 papers (2015–2019)Qin Guo · Institute of Food Science and Technology12 papers (2016–2019)Chen Jiang · Fudan University12 papers (2015–2018)Chen Jiang · Fudan University11 papers (2015–2020)Chunhui Ruan · Fudan University9 papers (2016–2018)Yu Zhang · Tsinghua University8 papers (2015–2019)Lisha Liu · Fudan University8 papers (2016–2019)Wenxi Zhou · New York University7 papers (2018–2020)Qin Guo · Inner Mongolia Normal University6 papers (2017–2020)Sai An · Fudan University5 papers (2015–2017)Yiwen Zhang · Fudan University4 papers (2019–2020)Xutao Jiang · Fudan University4 papers (2015–2017)Donghui Liang · Fudan University4 papers (2018–2019)Chao Li · Fudan University4 papers (2018–2019)Jianfeng Li · Donghua University3 papers (2015–2017)Lisha Liu · China Pharmaceutical University3 papers (2016–2018)Peixin Liu · Fudan University3 papers (2019–2020)